4//SEC Filing
Cytosorbents Corp 4
Accession 0001144204-13-039902
$CTSOCIK 0001175151operating
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 2:50 PM ET
Size
8.3 KB
Accession
0001144204-13-039902
Insider Transaction Report
Form 4
Gunton James T.
Director
Transactions
- Award
Common Stock
2013-04-04$0.11/sh+75,472$8,000→ 75,472 total(indirect: By Partnership) - Award
Stock Option
2013-04-04+150,000→ 489,000 total(indirect: By Partnership)Exercise: $0.12Exp: 2023-04-04→ Common Stock (150,000 underlying)
Footnotes (4)
- [F1]These shares were received in lieu of cash payment for the Company stipend given to directors.
- [F2]These securities are held directly by NJTC Venture Fund SBIC, LP, of which the Reporting Person is a partner. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended or any other purpose.
- [F3]The options will become exercisable based on the achievement of certain milestones connected to the Company's operations, subject to approval by the Board of Directors.
- [F4]As compensation for services rendered, on April 4, 2013, Mr. James Gunton on behalf of NJTC Venture Fund SBIC, LP was issued an option to purchase 150,000 shares of common stock at an exercise price of $0.115 per share which will expire on April 4, 2023.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001175151
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 2:50 PM ET
- Size
- 8.3 KB